Rallybio Corporation (RLYB)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Rallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement

Combined company to operate as Avenzo Therapeutics, advancing a leading portfolio of next-generation oncology therapies, including small...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form RW - Registration Withdrawal Request

Form 8-K - Current report

Form S-4/A - Registration of securities, business combinations: [Amend]

Form 8-K - Current report